Birnkrant D - Search Results

1

Considerations and Challenges in the Remdesivir COVID-19 Pediatric Development Program.

Chan-Tack K, Sampson M, Earp J, Arya V, Yao L, Alexander J, Hausman E, Belew Y, Birnkrant D, Struble K. Chan-Tack K, et al. Among authors: birnkrant d. J Clin Pharmacol. 2023 Feb;63(2):259-265. doi: 10.1002/jcph.2158. Epub 2022 Oct 4. J Clin Pharmacol. 2023. PMID: 36149807 Free PMC article.

2

Reporting of deaths during pre-approval clinical trials for advanced HIV-infected populations.

Johann-Liang R, James AN, Behr VL, Struble K, Birnkrant DB. Johann-Liang R, et al. Drug Saf. 2005;28(7):559-64. doi: 10.2165/00002018-200528070-00001. Drug Saf. 2005. PMID: 15963004 Review.

3

Atazanavir-associated nephrolithiasis: cases from the US Food and Drug Administration's Adverse Event Reporting System.

Chan-Tack KM, Truffa MM, Struble KA, Birnkrant DB. Chan-Tack KM, et al. AIDS. 2007 May 31;21(9):1215-8. doi: 10.1097/QAD.0b013e32813aee35. AIDS. 2007. PMID: 17502736

4

Intracranial hemorrhage and liver-associated deaths associated with tipranavir/ritonavir: review of cases from the FDA's Adverse Event Reporting System.

Chan-Tack KM, Struble KA, Birnkrant DB. Chan-Tack KM, et al. AIDS Patient Care STDS. 2008 Nov;22(11):843-50. doi: 10.1089/apc.2008.0043. AIDS Patient Care STDS. 2008. PMID: 19025478 Review.

5

Running a tightrope: regulatory challenges in the development of antiretrovirals.

Naeger LK, Struble KA, Murray JS, Birnkrant DB. Naeger LK, et al. Antiviral Res. 2010 Jan;85(1):232-40. doi: 10.1016/j.antiviral.2009.07.016. Epub 2009 Aug 7. Antiviral Res. 2010. PMID: 19665489 Review.

6

Use of ribavirin to treat influenza.

Chan-Tack KM, Murray JS, Birnkrant DB. Chan-Tack KM, et al. N Engl J Med. 2009 Oct 22;361(17):1713-4. doi: 10.1056/NEJMc0905290. N Engl J Med. 2009. PMID: 19846864 No abstract available.

7

Emergency use authorization for intravenous peramivir: evaluation of safety in the treatment of hospitalized patients infected with 2009 H1N1 influenza A virus.

Sorbello A, Jones SC, Carter W, Struble K, Boucher R, Truffa M, Birnkrant D, Gada N, Camilli S, Chan I, Dallas S, Scales T, Kosko R, Thompson E, Goodman J, Francis H, Dal Pan G. Sorbello A, et al. Among authors: birnkrant d. Clin Infect Dis. 2012 Jul;55(1):1-7. doi: 10.1093/cid/cis351. Epub 2012 Apr 5. Clin Infect Dis. 2012. PMID: 22491501

8

Meta-analysis of gender differences in efficacy outcomes for HIV-positive subjects in randomized controlled clinical trials of antiretroviral therapy (2000-2008).

Soon GG, Min M, Struble KA, Chan-Tack KM, Hammerstrom T, Qi K, Zhou S, Bhore R, Murray JS, Birnkrant DB. Soon GG, et al. AIDS Patient Care STDS. 2012 Aug;26(8):444-53. doi: 10.1089/apc.2011.0278. Epub 2012 Jun 26. AIDS Patient Care STDS. 2012. PMID: 22734949

9

Clinical experience with intravenous zanamivir under an Emergency IND program in the United States (2011-2014).

Chan-Tack KM, Kim C, Moruf A, Birnkrant DB. Chan-Tack KM, et al. Antivir Ther. 2015;20(5):561-4. doi: 10.3851/IMP2944. Epub 2015 Feb 10. Antivir Ther. 2015. PMID: 25667992 Review.

10

Benefit-risk assessment for sofosbuvir/velpatasvir/voxilaprevir based on patient population and hepatitis C virus genotype: U. S. Food and Drug Administration's evaluation.

Struble K, Chan-Tack K, Qi K, Naeger LK, Birnkrant D. Struble K, et al. Among authors: birnkrant d. Hepatology. 2018 Feb;67(2):482-491. doi: 10.1002/hep.29601. Epub 2018 Jan 1. Hepatology. 2018. PMID: 29059462

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99 results

Search Page

Filters